Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-14-Speech-4-338-750"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20120614.22.4-338-750"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Breast surgery is today one of the most common cosmetic surgeries in Europe. The manufacturing by French company PIP of implants made from industrial silicone, a material which is strictly prohibited for use in medical products, has raised a number of concerns, particularly because several patients who have received these implants will have to undergo another operation. Fortunately, these aberrations are rare thanks to stricter health standards at both national and European level. However, they are primarily the result of fierce competition between certain medical operators looking to use the cheapest possible raw materials to the detriment of patients’ health and public health. The text adopted calls for the reinforcement of these standards and notably greater cooperation between Member States with regard to controls on medical devices, and the implementation of a system of pre-market authorisation for certain categories of products by the Commission. Mindful of supporting anything that is a step towards better health protection, I voted in favour of this resolution."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples